Credit Suisse’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.1M | Buy |
|
|||||
|
2023
Q4 | $2.44M | Sell |
|
|||||
|
2023
Q3 | $1.56M | Sell |
|
|||||
|
2023
Q2 | $3.25M | Buy |
|
|||||
|
2023
Q1 | $2.54M | Buy |
|
|||||
|
2022
Q4 | $2.9M | Sell |
|
|||||
|
2022
Q3 | $655K | Buy |
|
|||||
|
2022
Q2 | $606K | Buy |
|
|||||
|
2022
Q1 | $804K | Buy |
|
|||||
|
2021
Q4 | $564K | Sell |
|
|||||
|
2021
Q3 | $615K | Buy |
|
|||||
|
2021
Q2 | $601K | Sell |
|
|||||
|
2021
Q1 | $1.05M | Sell |
|
|||||
|
2020
Q4 | $1.67M | Buy |
|
|||||
|
2020
Q3 | $1.22M | Sell |
|
|||||
|
2020
Q2 | $2.52M | Buy |
|
|||||
|
2020
Q1 | $863K | Sell |
|
|||||
|
2019
Q4 | $1.99M | Buy |
|
|||||
|
2019
Q3 | $729K | Buy |
|
|||||
|
2019
Q2 | $687K | Sell |
|
|||||
|
2019
Q1 | $871K | Sell |
|
|||||
|
2018
Q4 | $799K | Buy |
|
|||||
|
2018
Q3 | $1.23M | Sell |
|
|||||
|
2018
Q2 | $2.46M | Buy |
|
|||||
|
2018
Q1 | $677K | Buy |
|
|||||
|
2017
Q4 | $462K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $69K | Buy |
|
|||||
|
2016
Q1 | $5K | Sell |
|
|||||
|
2015
Q4 | $11K | Sell |
|
|||||
|
2015
Q3 | $56K | Sell |
|
|||||
|
2015
Q2 | $340K | Buy |
|
|||||
|
2015
Q1 | $129K | Sell |
|
|||||
|
2014
Q4 | $423K | Sell |
|
|||||
|
2014
Q3 | $608K | Sell |
|
|||||
|
2014
Q2 | $996K | Buy |
|
|||||
|
2014
Q1 | $912K | Buy |
|
|||||
|
2013
Q4 | $964K | Buy |
|
|||||
|
2013
Q3 | $851K | Sell |
|
|||||
|
2013
Q2 | $1.27M | Buy |
|